Multiplex Biomarker Imaging Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

12/mar/2018 10:45:06 pbi Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Market Outline: Multiplex Biomarker Imaging Market 

Multiplex biomarker imaging is a technique carried to characterize and analyze the disease present in the body. Biomarkers are used in clinical studies to determine the diseases progress. Multiplex biomarkers have a major role in the medical industry and these are used in alone or combination to determine the characteristics and evaluate as an indicator of biological process. Multiplex biomarkers also help in the study of biological system by providing analysis to check the expression of various biomarkers.

 

Market Dynamics: Multiplex Biomarker Imaging Market

Increase in the adoption of the multiplex biomarker in immunology and oncology research, growing R&D investments by pharmaceutical and biotechnology companies, increase in demand for personalized medicine, and innovation of newer technologies in biomarker imaging are anticipated to fuel the multiplex biomarker imaging market over the forecast period. Moreover, increase in preference for companion diagnostics and advantages of multiplex biomarker imaging over conventional methods are anticipated to boost the multiplex biomarker imaging market over the forecast years. However, the high cost of the instruments, ethical issues of biomarker imaging techniques, and stringent regulatory policies are anticipated to impede the growth of multiplex biomarker imaging market.

 

   A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/multiplex-biomarker-imaging-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

 

Market Scope: Multiplex Biomarker Imaging Market

Multiplex biomarker imaging market is segmented on the basis of product type, imaging technique, application, and end user

Based on the product type, the market is segmented into the following:

·         Instrument

·         Reagents and Kits

·         Software

Based on the imaging technique, the market is segmented into the following:

·         Tissue Microarray (TMA)

·         Toponome Imaging System (TIS)

·         Fluorescent In The Situ Hybridization (FISH)

·         Immunofluorescence Assay (IF)

·         Immunohistochemistry Assay (IHC)

Based on the application, the market is segmented into the following:

·         Oncology

·         Immunology

·         Drug Safety

·         Drug Discovery

Based on the end user, the market is segmented into the following:

·         Biotechnology and Pharmaceutical Companies

·         Academic Research Institutes

·         Contract Research Organizations

 

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/multiplex-biomarker-imaging-market/#ulp-c654SbFYO64MsOhu

 

 

Market Summary: Multiplex Biomarker Imaging Market

Multiplex biomarker imaging market expected to exhibit significant growth due to successful determination and validation of clinical data for various diseases related to cancer cells and immune cells. Majority of the market players are actively involved in the development of newer products and techniques to determine the disease progress. For instance, in December 2015, PerkinElmer, Inc. launched Vectra 3 system used to determine the deeper level analysis of disease mechanisms related to newer cancer immunotherapy approaches. Moreover, in September 2017, Aushon BioSystems and ABL, Inc. announced the adoption of Cira platform for ultrasensitive and multiplex biomarker analysis.

 

   Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/multiplex-biomarker-imaging-market/#ulp-14mlyhjMGhVjZqa3

 

 

Regional Analysis:  Multiplex Biomarker Imaging Market

Geographically, global multiplex biomarker imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America multiplex biomarker imaging market is driven by increase in the R&D activities for drug discovery, innovation of newer assays, and launching of newer products for multiplex biomarker imaging in the market. Europemultiplex biomarker imaging market has a significant share, which is attributed to adoption of newer technologies, presence of huge number of biotechnology research institutions, and increase in the prevalence of cancer and other immune disorders in the region. Asia Pacific multiplex biomarker imaging market has a lucrative growth opportunity owing to ongoing research for cancer and tumor, rise in prevalence of cancer, and growing R&D activities by pharmaceutical companies for drug discovery and drug safety are expected to bolster the market. Latin America multiplex biomarker imaging market is poised to grow at a significant rate due to increase in the biotech R&D activities by collaboration between the market players and increase in the demand for drug safety are expected to propel the market. Middle East and Africa multiplex biomarker imaging market is projected to grow due to increase in the prevalence of immune disorders in Africa region and increase in the preference for personalized medicine are expected to upsurge market revenue growth.

 

Competition Assessment: Multiplex Biomarker Imaging Market

Some of the players in the global multiplex biomarker imaging market include:

·         Bio-rad Laboratories Inc. (U.S.)

·         Abcam plc. (U.K.)

·         Perkin Elmer, Inc. (U.S.)

·         Thermo Fisher Scientific, Inc. (U.S.)

·         Merck KGaA (Germany)

·         Aushon BioSystems Ltd. (U.S.)

·         ToposNomos Ltd (Germany)

·         Ventana Medical Systems, Inc. (U.S.)

·         US Biomax Inc. (U.S.)

·         Quanterix (U.S.)

 

Notable Market Developments: Multiplex Biomarker Imaging Market

·         In August 2017, Quanterix launched high-sensitivity instrument Quanterix SR-Plex and assays for multiplex biomarker detection

 

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

 

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/multiplex-biomarker-imaging-market/

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl